JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, W. S.

Journal of the American Podiatric Medical Association, Vol 87, Issue 11 520-531, Copyright © 1997 by American Podiatric Medical Association

JOURNAL ARTICLE

Oral treatment options for onychomycosis

WS Joseph
Pennsylvania College of Podiatric Medicine, Philadelphia 19107, USA.

The author discusses the new oral antifungal agents for the treatment of onychomycosis. The history, mechanisms of action, efficacies, dosing, safety profiles, and costs of itraconazole, terbinafine, and fluconazole are reviewed. The author emphasizes that use of these effective antifungals represents an important paradigm shift for podiatric physicians away from the palliative therapy of nail debridement to a potentially curative treatment.


This article has been cited by other articles:


Home page
 J. Am. Podiatr. Med. Assoc.Home page
J. J. Anarella, C. Toth, and J. A. DeBello
Preventing Complications in the Diabetic Patient with Toenail Onychomycosis
J Am Podiatr Med Assoc, June 1, 2001; 91(6): 325 - 328.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Podiatric Medical Association.